Development and validation of a symptom assessment tool for postmicturition dribble: A prospective, multicenter, observational study in Korea.

08:00 EDT 11th October 2019 | BioPortfolio

Summary of "Development and validation of a symptom assessment tool for postmicturition dribble: A prospective, multicenter, observational study in Korea."

Postmicturition dribble (PMD) is a very common symptom in males with lower urinary tract symptoms (LUTS) worldwide, but there is no adequate questionnaire to assess it. Therefore, we developed a questionnaire named the Hallym Post Micturition Dribble Questionnaire (HPMDQ) to assess PMD, and the aim of this study is to validate it.


Journal Details

This article was published in the following journal.

Name: PloS one
ISSN: 1932-6203
Pages: e0223734


DeepDyve research library

PubMed Articles [22269 Associated PubMed Articles listed on BioPortfolio]

The Role of a Symptom Assessment Tool in Shaping Patient-Physician Communication in Palliative Care.

Patients with cancer experience many symptoms that disrupt quality of life, and symptom communication and management can be challenging. The Edmonton Symptom Assessment System (ESAS) was developed to ...

Validation of the Malawi Developmental Assessment Tool for children in the Dominican Republic: Preliminary results.

This study initiated the validation process of a translated and adapted version of the Malawi Developmental Assessment Tool (MDAT) for children in the Dominican Republic (DR). Like Malawi before the d...

Transcultural Validation of the French Version of the Modified Edmonton Symptom Assessment Scale: The ESAS12-F.

Cancer-related physical symptoms can decrease patients' overall quality of life and are often underdiagnosed. The Edmonton Symptom Assessment Scale (ESAS) is widely used in palliative care for cancer ...

Assessing depression improvement with the remission evaluation and mood inventory tool (REMIT).

The Remission Evaluation and Mood Inventory Tool (REMIT) was developed as a brief complementary measure to provide a more robust assessment of depression improvement than tracking DSM-V symptom improv...

Symptom screening in paediatrics tool for screening multiple symptoms in Brazilian patients with cancer: a cross-sectional validation study.

The objective of this study was to translate, culturally adapt and validate the Symptom Screening in Paediatrics Tool (SSPedi) into the Brazilian Portuguese language to be used by paediatric oncology ...

Clinical Trials [10586 Associated Clinical Trials listed on BioPortfolio]

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

This study will test an investigational vaccine, called DRibbles, for the treatment of non-small cell lung cancer (NSCLC). We hypothesize that vaccination with the DRibble vaccine will cau...

Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs

The purpose of this study is to develop and validate a comprehensive and standardised tool for assessment of patient needs in palliative care.

Psychometric Validation of the ESAS12-F

Assessing symptoms of patients with cancer should be a priority for the physicians to improve their quality of life. The Edmonton Symptom Assessment Scale (ESAS) is a common tool, easy to ...

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening t...

Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient

The objective of this study is to validate a diagnostic tool severity of these common non-motor manifestations, disturbing and little recognized as a self-questionnaire. This assessment to...

Medical and Biotech [MESH] Definitions

Prospective risk assessment tool aimed at identifying potential risks and their impact in healthcare settings.

The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.

A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87)

Evaluation of manifestations of disease.

The Commission was created by the Balanced Budget Act of 1997 under Title XVIII. It is specifically charged to review the effect of Medicare+Choice under Medicare Part C and to review payment policies under Parts A and B. It is also generally charged to evaluate the effect of prospective payment policies and their impact on health care delivery in the US. The former Prospective Payment Assessment Commission (ProPAC) and the Physician Payment Review Commission (PPRC) were merged to form MEDPAC.

Quick Search

DeepDyve research library

Relevant Topic

Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Searches Linking to this Article